Ligand validation:6BON

OAA: OXALOACETATE ION

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6BON_OAA_A_501	27%	25%	0.135	0.778	2.14	1.1	2	-	0	0	100%	1
6BON_OAA_B_503	5%	24%	0.435	0.845	2.14	1.12	1	-	3	0	100%	0.5
6BON_OAA_B_502	5%	17%	0.434	0.836	2.49	1.28	1	2	3	0	100%	0.5
5UQR_OAA_A_501	83%	4%	0.085	0.942	2.81	2.99	1	5	0	0	100%	1
6BOO_OAA_D_501	56%	23%	0.118	0.891	2.02	1.31	1	1	0	0	100%	1
5UQU_OAA_A_502	33%	12%	0.152	0.827	2.29	2.02	2	1	0	0	100%	1
6BOL_OAA_A_501	9%	46%	0.232	0.728	0.16	1.91	-	1	0	0	100%	1
1AL6_OAA_A_702	100%	18%	0.038	0.992	1.18	2.5	-	5	0	0	100%	1
8GR9_OAA_A_508	94%	18%	0.079	0.977	2.15	1.53	4	1	0	0	100%	1
5ZI4_OAA_B_401	92%	22%	0.081	0.971	2.58	0.89	2	-	1	0	100%	1
2IFC_OAA_B_385	89%	13%	0.074	0.951	2.5	1.65	4	2	0	0	100%	1
4ROS_OAA_A_403	82%	15%	0.1	0.957	1.65	2.3	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.